No abstract available
MeSH terms
-
Adrenergic alpha-2 Receptor Agonists
-
Adrenergic alpha-Agonists / adverse effects*
-
Adrenergic alpha-Agonists / pharmacokinetics
-
Adrenergic alpha-Agonists / therapeutic use
-
Adult
-
Antidepressive Agents, Tricyclic / adverse effects*
-
Antidepressive Agents, Tricyclic / pharmacokinetics
-
Antidepressive Agents, Tricyclic / therapeutic use
-
Azabicyclo Compounds
-
Cytochrome P-450 Enzyme Inhibitors
-
Cytochrome P-450 Enzyme System / metabolism
-
Depression / drug therapy
-
Drug Therapy, Combination
-
Humans
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / metabolism
-
Male
-
Mianserin / adverse effects*
-
Mianserin / analogs & derivatives*
-
Mianserin / pharmacokinetics
-
Mianserin / therapeutic use
-
Mirtazapine
-
Piperazines / therapeutic use
-
Restless Legs Syndrome / chemically induced*
-
Valproic Acid / analogs & derivatives*
-
Valproic Acid / pharmacokinetics
-
Valproic Acid / therapeutic use
Substances
-
Adrenergic alpha-2 Receptor Agonists
-
Adrenergic alpha-Agonists
-
Antidepressive Agents, Tricyclic
-
Azabicyclo Compounds
-
Cytochrome P-450 Enzyme Inhibitors
-
Isoenzymes
-
Piperazines
-
zopiclone
-
Mianserin
-
Valproic Acid
-
Cytochrome P-450 Enzyme System
-
Mirtazapine
-
dipropylacetamide